Please circulate this announcement in your lab Call for contributions 
PhilInBioMed is both an interdisciplinary institute located at the University 
of Bordeaux, France, and a national and international network connecting groups 
and people working at the interface between philosophy, biology, and medicine, 
with the shared conviction that conceptual and philosophical approaches can 
make a critical contribution to science and medicine. The 2nd Meeting of the 
PhilInBioMed Network will take place on October 14th-15th 2019. The organizing 
committee welcomes abstracts for 30 minute oral presentations (20 minutes + 10 
minutes for Q&A) on any subject combining biological or medical science with a 
conceptual or philosophical approach in such a way that the resulting paper 
makes an important contribution from both a scientific and a philosophical 
point of view.

Abstracts must be submitted to Lucie Laplane by May 30th, 2019.
Notifications will be sent on June 21st at the latest.

The submission must contain:
–          Name(s) of author(s)
–          Institutional affiliations & position
–          Title of the talk
–          Abstract: no longer than 500 words. The abstract must show as 
clearly as possible how the talk can contribute to both philosophy and biology 
/ medicine.

Funding
Stipends to attend the meeting will be awarded to up to 10 students or young 
researchers (Master or PhD students, or postdoctoral researchers), based on the 
quality of the proposal (amount: between €500 and €1,000 each).

Publication
The best contributions will be submitted to a leading journal as a special 
issue, edited by Lucie Laplane, Maël Lemoine, and Thomas Pradeu. For more 
information click here. Best regards, Wiebke Bretting
--
Dr. Wiebke Bretting
Project Manager ERC IDEM
ImmunoConcEpT, UMR5164
Université de Bordeaux
146 rue Léo Saignat
33076 Bordeaux
https://www.immuconcept.org/erc-idem/

--
Pour toute question, la FAQ de la liste se trouve ici:  
https://www.vidal-rosset.net/
        
        
        
        
        
        
        
        
        
        
        
        
        
        

Répondre à